Learning to Trust genAI
Drug sponsors are asking 3 key questions: Generative AI provides a once-in-a-generation opportunity to fundamentally move the needle on development speed, resource […]
FDA Executive Summary For The Digital Heath Advisory Committee Meeting: Total Product Lifecycle Considerations for Generative AI-Enabled Devices (Nov 2024)
In a risk-adverse world, adopting generative AI may seem like a daunting task. FDA’s recently published “Executive Summary For The Digital Heath […]